DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Braskem S.A.

BME:XBRK Stock Report

Market Cap: €587.0m

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Braskem Past Earnings Performance

Past criteria checks 0/6

Braskem's earnings have been declining at an average annual rate of -61.9%, while the Chemicals industry saw earnings declining at 3.5% annually. Revenues have been declining at an average rate of 8.7% per year.

Key information

-61.87%

Earnings growth rate

-61.88%

EPS growth rate

Chemicals Industry Growth13.08%
Revenue growth rate-8.68%
Return on equityn/a
Net Margin-7.85%
Next Earnings Update12 Nov 2026

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Braskem makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BME:XBRK Revenue, expenses and earnings (BRL Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2670,603-5,5404,835431
31 Mar 2666,745-9,1324,836436
31 Dec 2570,717-9,8804,807460
30 Sep 2573,768-5,2424,945497
30 Jun 2577,733-5,8094,826485
31 Mar 2578,951-9,2774,552483
31 Dec 2477,411-11,3204,522463
30 Sep 2474,950-7,2484,401437
30 Jun 2470,362-9,0734,367420
31 Mar 2469,043-6,1084,520395
31 Dec 2370,569-4,5794,471383
30 Sep 2372,867-4,7154,637386
30 Jun 2381,578-3,4004,746398
31 Mar 2389,234-4,0364,846395
31 Dec 2296,519-3364,910374
30 Sep 22105,7421,9054,921354
30 Jun 22108,6546,5454,910323
31 Mar 22109,66415,3754,767307
31 Dec 21105,62513,9854,587297
30 Sep 2196,15114,3014,331276
30 Jun 2183,8449,3514,074265
31 Mar 2168,611-5483,908257
31 Dec 2058,543-6,6923,826251
30 Sep 2052,445-10,4603,866251
30 Jun 2049,821-9,9353,952246
31 Mar 2051,970-7,3754,028248
31 Dec 1952,324-2,7984,015248
30 Sep 1954,520463,886235
30 Jun 1957,5002,2783,888244
31 Mar 1957,9492,7413,614235
31 Dec 1858,0002,8673,395219
30 Sep 1855,7923,1143,191210
30 Jun 1851,6052,5692,924181
31 Mar 1849,6903,3292,913173
31 Dec 1749,2613,8572,894167
30 Sep 1748,6781,1532,835153
30 Jun 1748,4981,2382,781152
31 Mar 1748,3495482,754153
31 Dec 1647,664-4382,689162
30 Sep 1647,5472,1882,563170
30 Jun 1648,7292,8702,480170
31 Mar 1648,5993,5562,397172
31 Dec 1546,8802,9952,173170
30 Sep 1546,5622,9652,384157

Quality Earnings: XBRK is currently unprofitable.

Growing Profit Margin: XBRK is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: XBRK is unprofitable, and losses have increased over the past 5 years at a rate of 61.9% per year.

Accelerating Growth: Unable to compare XBRK's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: XBRK is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (7.5%).


Return on Equity

High ROE: XBRK's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/18 23:01
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Braskem S.A. is covered by 23 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAlembic Global Advisors
Daniel CobucciBB Banco de Investimento S.A.
Leonardo MarcondesBofA Global Research

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide